Policy | Behavioral Healthcare Executive Skip to content Skip to navigation


Senate tweaks won’t change big cuts to Medicaid

June 28, 2017  |  Julie Miller, Editor in Chief

Behavioral health leaders are pressing forward with their opposition, drawing a detailed picture of what healthcare would look like for individuals with mental health or substance use disorders if the Senate bill is implemented.

The Smile: Trading lives for premium rebates and tax reductions

June 22, 2017  |  Ron Manderscheid, PhD, Executive Director, NACBHDD and NARMH

On Thursday, the Senate released its healthcare bill. The shroud hiding the underlying calculus has disappeared like the smiling Cheshire cat of yore. All that remains is the smile.

The least you need to know about the Senate healthcare bill

June 22, 2017  |  Julie Miller, Editor in Chief

Whether the Senate version of health reform policy that was released as a draft today is a viable option will be decided by Congress as early as next week. Here is the least you need to know.

'Heartless' Senate bill slashes Medicaid, offers $2 billion in opioid funds

June 22, 2017  |  Julie Miller, Editor in Chief

President Trump said the Senate bill should have more “heart,” but industry experts reviewing the draft after its release today don’t believe it contains any heart at all. For one, the bill would end Medicaid expansion in 2020.

Insurers not providing sufficient evidence of parity act compliance

June 22, 2017  |  Tom Valentino, Senior Editor

A recently analysis finds insurers are not providing consumers or state regulators with adequate documentation about their plans’ mental health and addiction treatment benefits.

New bipartisan bill revisits IMD issue

June 7, 2017  |  Julie Miller, Editor in Chief

The Medicaid Coverage for Addiction Recovery Expansion (CARE) Act would allow Medicaid payment to residential addiction treatment facilities with up to 40 beds—an increase over the current 16 bed limit. It would also allow for treatment services for up to...

Need for buprenorphine demonstrated in Medicaid data

June 7, 2017  |  Julie Miller, Editor in Chief

A new brief from the Urban Institute shows that Medicaid programs nationwide have seen increases in buprenorphine prescriptions since the launch of the Affordable Care Act, but trends are higher in expansion states.

Rumored gutting of ONDCP agenda does not materialize in president's budget plan

May 24, 2017  |  Gary A. Enos, Contributing Editor

Most core functions of the Office of National Drug Control Policy, including oversight of the Drug-Free Communities Support Program, are preserved in President Trump's fiscal 2018 budget proposal.

The US Senate can improve health reform

May 12, 2017  |  Ron Manderscheid, PhD, Exec Dir, NACBHDD and NARMH

The behavioral health community is dismayed by the recent vote in the House to approve the American Health Care Act (AHCA). We hope that considerably more reasonable decisions will prevail in the Senate.

Is the American Health Care Act rising from the dead?

May 3, 2017  |  Walter H. Boone

What does the rise of the American Health Care Act and the MacArthur Amendment mean for the alcohol and drug treatment industry?

Will you join us in this Herculean effort?

May 1, 2017  |  Ron Manderscheid, PhD, Executive Director, NACBHDD and NARMH

Federal officials are choosing deliberately to make it more difficult and more costly for those with pre-existing conditions, those with disabilities, and those who are older to access necessary healthcare. We must work immediately to defeat AHCA.

Why you need to be concerned about the next drug czar

April 12, 2017  |  Julie Miller, Editor in Chief

Behavioral healthcare stakeholders might have a reason to drop what they’re doing—right now—and get on the phone to anyone in Washington who will listen.


Subscribe to Policy